1. Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells;Abdul-Ahad;Cytokines Cell Mol Ther,1997
2. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes;Boven;Kidney Int,2005
3. The immunogenicity of insulin preparations;Chance;Acta Endocrinol Suppl (Copenh),1976
4. Characterizing biological products and assessing comparability following manufacturing changes;Chirino;Nat Biotechnol,2004
5. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation;Cleland;Crit Rev Ther Drug Carrier Syst,1993